IgG4相关性疾病损害指数的制定与初步验证:中国IgG4-RD协作组共识报告
中国IgG4-RD协作组通过Delphi法制订了涵盖14个器官系统、39个条目的累积性IgG4-RD损害指数(DI),并由48名风湿科医生对40例代表4类临床场景、随访至少3年的病例进行初步验证;两个时间点评分者间ICC为0.69和0.70,KW为0.74和0.73,效标效度灵敏度0.86(95%CI 0.82至0.88)、特异度0.79(95%CI 0.76至0.82)、曲线下面积0.88(95%CI 0.85至0.91)。
要点
- IgG4-RD DI为累积性指数,含14个器官系统域、共39个条目。
- 两个时间点评分者间ICC为0.69和0.70,KW为0.74和0.73。
- 效标效度灵敏度0.86(95%CI 0.82至0.88)、特异度0.79(95%CI 0.76至0.82)。
核心结论
- IgG4-RD DI是分析疾病结局的有用方法,具有良好的可操作性和可信度。
- 作者预期该DI将成为IgG4-RD患者治疗试验和预后研究的有用工具。
研究设计与样本
- 由中国IgG4-RD协作组(CIC)专家生成评估IgG4-RD患者器官损害的条目草案。
- 采用Delphi法对初步DI进行修订,并通过共识生成最终版本。
- 选取40例代表4类临床场景的IgG4-RD病例,每例设两个评估时间点,随访至少3年。
- 邀请来自全国35家医院的48名风湿科医生使用CIC IgG4-RD DI评估器官损害。
- 采用组内相关系数(ICC)和Kendall-W和谐系数(KW)评估评分者间信度,通过计算评分者的灵敏度和特异度检验效标效度。
主要发现
- IgG4-RD DI为累积性指数,由14个器官系统域组成,共包括39个条目。
- IgG4-RD DI能够区分活动性疾病亚组和稳定疾病亚组中的稳定损害与增加损害。
- 全部评分者在基线和后续观察中的总体评分一致性令人满意,两个时间点的ICC分别为0.69和0.70,KW分别为0.74和0.73。
- 亚组分析中,所有亚组的ICC和KW分别均超过0.55和0.61。
- 效标效度分析显示良好性能,灵敏度为0.86(95%CI 0.82至0.88),特异度为0.79(95%CI 0.76至0.82),曲线下面积为0.88(95%CI 0.85至0.91)。
关键数值与推荐
- IgG4-RD DI包含14个器官系统域、共39个条目。
- 两个时间点评分者间ICC为0.69和0.70,KW为0.74和0.73。
- 亚组分析中所有亚组ICC均超过0.55,KW均超过0.61。
- 效标效度灵敏度0.86(95%CI 0.82至0.88),特异度0.79(95%CI 0.76至0.82),曲线下面积0.88(95%CI 0.85至0.91)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop and conduct an initial validation of the Damage Index for IgG4-related disease (IgG4-RD DI). METHODS: A draft of index items for assessing organ damages in patients with IgG4-RD was generated by experts from the Chinese IgG4-RD Consortium (CIC). The preliminary DI was refined using the Delphi method, and a final version was generated by consensus. 40 IgG4-RD cases representing four types of clinical scenarios were then selected, each with two time points of assessment for at least 3 years of follow-up. 48 rheumatologists from 35 hospitals nationwide were invited to evaluate organ damage using the CIC IgG4-RD DI. The intraclass correlation coefficient (ICC) and the Kendall-W coefficient of concordance (KW) were used to assess the inter-rater reliability. The criterion validity of IgG4-RD DI was tested by calculating the sensitivity and specificity of raters. RESULTS: IgG4-RD DI is a cumulative index consisting of 14 domains of organ systems, including a total of 39 items. The IgG4-RD DI was capable of distinguishing stable and increased damage across the active disease subgroup and stable disease subgroup. In terms of scores at baseline and later observations by all raters, overall consistency in scores at baseline and later observations by all raters was satisfactory. ICC at the two time points was 0.69 and 0.70, and the KW was 0.74 and 0.73, respectively. In subgroup analysis, ICC and KW in all subgroups were over 0.55 and 0.61, respectively. The analysis of criterion validity showed a good performance with a sensitivity of 0.86 (95% CI 0.82 to 0.88), a specificity of 0.79 (95% CI 0.76 to 0.82) and an area under the curve of 0.88 (95% CI 0.85 to 0.91). CONCLUSION: The IgG4-RD DI is a useful approach to analyse disease outcomes, and it has good operability and credibility. It is anticipated that the DI will become a useful tool for therapeutic trials and studies of prognosis in patients with IgG4-RD.
引用
- Peng L, Li J, Zhou J, et al. The development and initial validation of IgG4-related disease damage index: a consensus report from Chinese IgG4-RD Consortium. RMD Open. 2024. PMID: 38458761. doi:10.1136/rmdopen-2023-003938
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。